FDA proposes to withdraw Amgen's drug for rare autoimmune diseases over effectiveness
FDA proposes to withdraw Amgen's Tavneos for autoimmune diseases over effectiveness concerns, advising healthcare professionals on alternatives.
28 Apr 07:33 · The Hindu